CHMP anbefalede derfor at fjerne den terapeutiske indikation "akut og kronisk kompliceret pyelonefritis" for lægemidler, der indeholder norfloxacin, i hele Europa.
Therefore, the CHMP recommended the removal of the therapeutic indication “ acute and chronic complicated pyelonephritis” for products containing norfloxacin throughout Europe.